DrugPatentWatch Database Preview
ALBUTEROL SULFATE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Albuterol Sulfate patents expire, and what generic alternatives are available?
The generic ingredient in ALBUTEROL SULFATE is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for ALBUTEROL SULFATE
| US Patents: | 0 |
| Applicants: | 34 |
| NDAs: | 67 |
| Suppliers / Packagers: | 38 |
| Bulk Api Vendors: | 83 |
| Clinical Trials: | 871 |
| Patent Applications: | 3,668 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ALBUTEROL SULFATE |
| DailyMed Link: | ALBUTEROL SULFATE at DailyMed |
Pharmacology for ALBUTEROL SULFATE
| Drug Class | beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists |
Synonyms for ALBUTEROL SULFATE
| .alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha.,.alpha.'-diol sulfate (2:1) salt |
| (+-)-Salbutamol sulfate |
| (C13H21NO3)2.H2SO4 |
| 022S709 |
| 1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate |
| 1, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, sulfate (2:1) (salt) |
| 1, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, sulfate (2:1) salt |
| 1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt) |
| 1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-,sulfate (2:1) (salt) |
| 1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt) |
| 2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol Hemisulfate |
| 2200AH |
| 34245-12-0 |
| 36519-31-0 |
| 39971-61-4 |
| 4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hemisulfate |
| 4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol sulfate |
| 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; sulfuric acid |
| 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid |
| 5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzyl Alcohol Hemisulfate |
| 51022-70-9 |
| AB0013333 |
| AB1009413 |
| AC-6369 |
| AC1L22LX |
| AccuNeb |
| Accuneb (TN) |
| Accuvent |
| Aerotec |
| AH-3365 |
| AK-51732 |
| AK158331 |
| AKOS015951296 |
| AKOS015994719 |
| Albuterol hemisulfate |
| Albuterol sulfate (USP) |
| Albuterol sulfate [USAN:USP] |
| Albuterol sulfate [USAN] |
| Albuterol sulfate, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Albuterol sulfate, United States Pharmacopeia (USP) Reference Standard |
| Albuterol Sulfate,(S) |
| Albuterol sulfate(1:x) |
| Albuterol sulfate(2:1) |
| Aloprol |
| alpha-([t-Butylamino]methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol |
| alpha-[(tert-Butylamino)methyl]-4-hydroxy-1,3-benzenedimethanol sulfate |
| alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol sulfate (2:1) (salt) |
| Amocasin |
| API0004123 |
| Asmaven sulfate |
| Asthavent |
| AX8292143 |
| BCP0726000244 |
| BG0312 |
| Bis((tert-butyl)(beta,3,4-trihydroxyphenethyl)ammonium) sulphate |
| bis(salbutamol); sulfuric acid |
| Broncho Inhalat |
| Bronchospray |
| Broncodil |
| Buventol Easyhaler |
| C13H21NO3??1/2H2SO4 |
| C13H21NO3.H2O4S |
| CA0122 |
| CCG-100775 |
| CCG-222402 |
| CHEBI:2550 |
| CHEMBL1201026 |
| CHEMBL1441059 |
| CPD000058513 |
| CTK4J3501 |
| D00683 |
| Dipulmin |
| dl-Salbutamol sulfate |
| Eae -Ae |
| EINECS 256-916-8 |
| Emican |
| Epaq |
| EU-0101098 |
| Fartolin |
| FT-0650809 |
| H886 |
| HMS2051A09 |
| HMS3263K18 |
| HMS3266D17 |
| HMS3393A09 |
| Huma-Salmol |
| Inspiryl |
| J10322 |
| K-9412 |
| KS-00000RSS |
| KS-5056 |
| KSC593K0D |
| Loftan |
| LP01098 |
| LS-162604 |
| LS-29862 |
| MFCD00055200 |
| MLS000758199 |
| MLS001423971 |
| MolPort-003-933-916 |
| MolPort-005-933-644 |
| NC00025 |
| NCGC00094370-01 |
| NCGC00261783-01 |
| NSC 289928 |
| NSC-289928 |
| NSC289928 |
| OR076774 |
| OVICLFZZVQVVFT-UHFFFAOYSA-N |
| Pediavent |
| Proair HFA |
| Proair Respiclick |
| Proventil Repetabs |
| Proventil Repetabs, Solution, Syrup, and Tablets |
| Proventil-HFA |
| Pulvinal salbutamol |
| S 5013 |
| S0531 |
| s2507 |
| Salbutamol Diskus |
| Salbutamol Easyhaler |
| Salbutamol hemisulfate |
| Salbutamol hemisulfate salt |
| Salbutamol hemisulfate salt, >=98% |
| Salbutamol hemisulfate salt, VETRANAL(TM), analytical standard |
| Salbutamol hemisulphate |
| Salbutamol sulfate |
| Salbutamol sulfate - Albuterol |
| Salbutamol sulfate (Albuterol) |
| Salbutamol sulfate (JP17) |
| Salbutamol sulfate for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Salbutamol sulfate, 99% 1g |
| Salbutamol sulfate, European Pharmacopoeia (EP) Reference Standard |
| Salbutamol sulfate(Albuterol) |
| salbutamol sulphate (albuterol sulphate) |
| Salbutamol Sulphate (Albuterol Sulphate) 1.0 mg/ml in Methanol (as free base) |
| salbutamol; sulfuric acid |
| SAM001246971 |
| SC-18559 |
| Sch 13949W sulfate |
| SCH-13949W |
| SCH-13949W Sulfate |
| SCHEMBL33279 |
| SCHEMBL33280 |
| SMR000058513 |
| TBS-7 |
| TL8003382 |
| Tox21_501098 |
| TQ-1016 |
| Venetlin |
| Ventolin |
| Ventolin (TN) |
| Ventolin easy-breathe |
| Ventolin HFA |
| Ventolin Nebules |
| Ventorlin |
| Volare |
| VoSpire ER |
US Patents and Regulatory Information for ALBUTEROL SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ritedose Corp | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 202496-001 | Oct 1, 2012 | AN | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Amneal Pharms Co | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 208804-002 | May 21, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Mova | ALBUTEROL SULFATE | albuterol sulfate | SYRUP;ORAL | 074302-001 | Sep 30, 1994 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Pliva | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 072317-001 | Dec 5, 1989 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
